4.7 Article

The challenge and promise of anti-epileptic therapy development in animal models

Journal

LANCET NEUROLOGY
Volume 13, Issue 9, Pages 949-960

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S1474-4422(14)70076-6

Keywords

-

Funding

  1. ILAE
  2. AES
  3. Citizens United for Research in Epilepsy (CURE)
  4. Epilepsy Therapy Project
  5. Autism Speaks

Ask authors/readers for more resources

Translation of successful target and compound validation studies into clinically effective therapies is a major challenge, with potential for costly clinical trial failures. This situation holds true for the epilepsies-complex diseases with different causes and symptoms. Although the availability of predictive animal models has led to the development of effective antiseizure therapies that are routinely used in clinical practice, showing that translation can be successful, several important unmet therapeutic needs still exist. Available treatments do not fully control seizures in a third of patients with epilepsy, and produce substantial side-effects. No treatment can prevent the development of epilepsy in at-risk patients or cure patients with epilepsy. And no specific treatment for epilepsy-associated comorbidities exists. To meet these demands, a redesign of translational approaches is urgently needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available